<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Franz-Ziel on Bioecon</title><link>https://en.bioecon.ru/companies/franz-ziel/</link><description>Recent content in Franz-Ziel on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 12 Aug 2026 00:22:25 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/franz-ziel/index.xml" rel="self" type="application/rss+xml"/><item><title>Aseptic isolators for pharma manufacturing</title><link>https://en.bioecon.ru/technology/aseptic-isolators-pharma/</link><pubDate>Tue, 11 Aug 2026 17:12:07 +0000</pubDate><guid>https://en.bioecon.ru/technology/aseptic-isolators-pharma/</guid><description>Rigid, fully sealed barrier enclosures that physically separate the sterile processing zone from the operator and surrounding room, using glove ports for manipulation and vaporized hydrogen peroxide for decontamination — the highest-assurance containment format for aseptic fill-finish, sterility testing and cell-therapy manufacturing, increasingly favored over open RABS under the EU&amp;rsquo;s revised Annex 1.</description></item></channel></rss>